Fig. 3 OncRNA-based liquid biopsy platform and Orion architecture. (IMAGE)
Caption
Fig. 3 OncRNA-based liquid biopsy platform and Orion architecture. a. Validation diagram of oncogenic RNAs (oncRNAs) for non-small cell lung cancer (NSCLC) using The Cancer Genome Atlas (TCGA) tissue datasets and non-cancer control samples; b. Schematic diagram of the two required input count matrices for the Orion model architecture; c. Schematic diagram of the application of triplet margin loss on simulated data; d. Loss convergence curve.
Credit
Haoran Meng et al.
Usage Restrictions
Credit must be given to the creator.
License
CC BY